Skip to content

The Effect of Instant Message Intervention for Psychological Well-being Among Stroke Survivors

The Effect of Instant Message Intervention for Psychological Well-being Among Stroke Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05490069
Enrollment
40
Registered
2022-08-05
Start date
2021-10-04
Completion date
2022-12-23
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Symptoms, Mobile Phone Use, Stroke

Brief summary

The proposed pilot trial aims to evaluate the feasibility of iCBT based EMI, which is a real-time, real-world, personalised and cost-effective approach, for stroke survivors' psychological well-being.

Interventions

Consists of brief iCBT for psychological support (mandatory), stroke care education (optional), and real-time chat-based support messages, delivered according to participants' preferences.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of stroke (ICD-10 codes: I60-I69) * Aged ≥18 * Able to read and communicate in Chinese (Cantonese or Putonghua) * Able to use text messaging function on mobile phones * MoCA 5-minute Protocol (cognitive screen) ≥14 (Equivalence to MMSE ≥ 21) * Discharged home from hospital within preceding 6 months * PHQ-9 (depressive symptom) score range from 5 to 19 (cf. mild: 5-9, moderate: 10-14, moderately severe: 15-19 and severe: 20-27)

Exclusion criteria

* Currently receiving active stroke care in acute or post-acute inpatient settings * Has diagnosis of psychiatric disease or is currently taking psychotropic drug * PHQ-9 ≥ 20 (i.e., severe depressive symptom) * Currently participating in any type of psychological intervention (e.g., CBT)

Design outcomes

Primary

MeasureTime frameDescription
Depressive symptoms (Patient Health Questionnaire-9 [PHQ-9])24-weekA 9-item scale with score ranging from 0 to 27, higher scores indicate higher severity of depressive symptom

Secondary

MeasureTime frameDescription
Anxiety symptoms (Generalized Anxiety Disorder-7 [GAD-7])24-weekA 7-item scale with score ranging from 0 to 21, higher scores indicate higher severity of anxiety symptoms
Stress level (Perceived Stress Scale [PSS-4])24-weekA 4-item scale with score ranging from 0 to 16, higher scores indicate higher severity of stress
Spiritual well-being (Sub-scale of Spirituality Scale for Chinese Elders [SSCE])24-weekAn 8-item scale with score ranging from 0 to 32, higher scores indicate better spiritual well-being
Loneliness (UCLA Loneliness Scale [ULS-8])24-weekAn 8-item scale with score ranging from 8 to 32, higher scores indicate higher level of loneliness

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026